AVITA Medical (AVHHL) FCF Margin (2019 - 2025)
AVITA Medical's (AVHHL) quarterly FCF Margin came in at 5.18% in Q4 2025, up 4727.0% on a YoY basis from 0.11% in Q4 2024, and up 85.63% quarter-over-quarter from 36.06% in Q3 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) FCF Margin (2019 - 2025) Analysis & Trends
AVITA Medical (AVHHL) has reported FCF Margin for 7 consecutive years, with 5.18% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin rose 4727.0% year-over-year to 5.18%; the trailing twelve-month figure through Dec 2025 stood at 22.06% (up 6832.0% YoY), and the FY2025 full-year result was 44.97%, up 4541.0% from the prior year.
- FCF Margin improved to 5.18% in Q4 2025 per AVHHL's latest filing, from 36.06% in the prior quarter.
- Across five years, FCF Margin topped out at 79.65% in Q4 2022 and bottomed at 198.23% in Q1 2024.
- Historically, FCF Margin has averaged 68.04% across 5 years, with a median of 69.45% in 2023.
- The sharpest annual moves came in 2023 and 2025: FCF Margin sank 15826 bps in 2023, then jumped 14394 bps in 2025.
- Over 5 years, FCF Margin stood at 53.25% in 2021, then jumped by 250 bps to 79.65% in 2022, then plunged by 199 bps to 78.61% in 2023, then jumped by 33 bps to 52.45% in 2024, then surged by 90 bps to 5.18% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 5.18%, 36.06%, and 60.99% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 18.73% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.18% |
| Sep 30, 2025 | -36.06% |
| Jun 30, 2025 | -60.99% |
| Mar 31, 2025 | -54.28% |
| Dec 31, 2024 | -52.45% |
| Sep 30, 2024 | -56.14% |
| Jun 30, 2024 | -101.56% |
| Mar 31, 2024 | -198.23% |
| Dec 31, 2023 | -78.61% |
| Sep 30, 2023 | -69.45% |
| Jun 30, 2023 | -79.98% |
| Mar 31, 2023 | -88.69% |
| Dec 31, 2022 | 79.65% |
| Mar 31, 2022 | -128.33% |
| Sep 30, 2021 | -53.25% |
| Jun 30, 2021 | -69.61% |
| Mar 31, 2021 | -103.47% |
| Dec 31, 2020 | -116.36% |
| Sep 30, 2020 | -156.56% |
| Jun 30, 2020 | -155.89% |